Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement.
Bézard M, Oghina S, Vitiello D, Kharoubi M, Kordeli E, Galat A, Zaroui A, Guendouz S, Gilles F, Shourick J, Hamon D, Audard V, Teiger E, Poullot E, Molinier-Frenkel V, Lemonnier F, Agbulut O, Le Bras F, Damy T.
Bézard M, et al. Among authors: gilles f.
PLoS One. 2021 Sep 15;16(9):e0257189. doi: 10.1371/journal.pone.0257189. eCollection 2021.
PLoS One. 2021.
PMID: 34525116
Free PMC article.
CONCLUSION: Delaying dexamethasone during the first chemotherapy cycle reduces the number of early deaths without extending survival. It is clear that dexamethasone is beneficial in the long-term treatment of patients with AL-CA. However, the initial introduction of dexame …
CONCLUSION: Delaying dexamethasone during the first chemotherapy cycle reduces the number of early deaths without extending survival. It is …